TY - JOUR T1 - Understand research hotspots surrounding COVID-19 and other coronavirus infections using topic modeling JF - medRxiv DO - 10.1101/2020.03.26.20044164 SP - 2020.03.26.20044164 AU - Mengying Dong AU - Xiaojun Cao AU - Mingbiao Liang AU - Lijuan Li AU - Guangjian Liu AU - Huiying Liang Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/04/10/2020.03.26.20044164.abstract N2 - Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a virus that causes severe respiratory illness in humans, which results in global outbreak of novel coronavirus disease (COVID-19) currently. This study aimed to evaluate the characteristics of publications involving coronaviruses as well as COVID-19 by using topic modeling.Methods We extracted all abstracts and retained the most informative words from the COVID-19 Open Research Dataset, which contains 35,092 pieces of coronavirus related literature published up to March 20, 2020. Using Latent Dirichlet Allocation modeling, we trained a topic model from the corpus, analyzed the semantic relationships between topics and compared the topic distribution between COVID-19 and other CoV infections.Results Eight topics emerged overall: clinical characterization, pathogenesis research, therapeutics research, epidemiological study, virus transmission, vaccines research, virus diagnostics, and viral genomics. It was observed that current COVID-19 research puts more emphasis on clinical characterization, epidemiological study, and virus transmission. In contrast, topics about diagnostics, therapeutics, vaccines, genomics and pathogenesis only account for less than 10% or even 4% of all the COVID-19 publications, much lower than those of other CoV infections.Conclusions These results identified knowledge gaps in the area of COVID-19 and offered directions for future research.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the National Key R&D Plan of China (grant number 2018YFC1315405), the National Natural Science Foundation of China (grant number 71704031), and the fund from Guangzhou Institute of Pediatrics/Guangzhou Women and Children’s Medical Center (grant numbers IP-2019-017, KCP-2016-002).Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll the data are publicly available (https://www.kaggle.com/allen-institute-for-ai/CORD-19-research-challenge/). https://www.kaggle.com/allen-institute-for-ai/CORD-19-research-challenge/ ER -